Characteristic features and surgical outcome in bisphosphonate-associated atypical femoral fracture: A retrospective observational study

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 241

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RIJO-9-4_001

تاریخ نمایه سازی: 9 آذر 1400

چکیده مقاله:

Background: Bisphosphonate-associated atypical femoral fracture (AFF) is a rare and serious ‎condition with poorly understood characteristics and management. ‎Objectives: To evaluate the characteristic features and outcomes of AFF in a two-center cohort ‎study.‎Methods: In a retrospective survey, medical profiles of ۲۲ AFF patients, who have used ‎alendronate for > ۱۲ months, were reviewed. The demographic characteristics such as age, ‎gender, and BMI, the clinical features including symptoms, symptom duration, radiologic ‎characteristics including fracture site, the severity of the fracture, and contralateral involvement, ‎surgical characteristics including the type of surgery union period and postoperative ‎complications such as fixation failure, and union problems were extracted from the patients’ ‎profiles.‎Results: The study population included ۴ males and ۱۸ females with a mean age ‎of ‎۷۰.۶±۱۱.۹ ‎ years. ‎The mechanism ‎of fracture was falling down‎ in ۲۱ (۹۵.۵% ) patients. The ‎mean duration of ‎bisphosphonate consumption was ‎‎۳.۸±۲ ‎‎ years. Prodromal symptoms (pain and ‎limping) were recorded in ۱۲ (۵۴.۵۵%) ‎patients. ‎The fracture was in the femoral shaft in ۱۵ ‎‎(۶۸.۲%) and in the subtrochanteric‎‎ in ۷ (‎‎۳۱.۸%) patients. ‎The fixation device was ‎the ‎intramedullary nail in ۱۸ (۸۱.۸%) and plate in ۴ (۱۸.۲%) patients. ‎The mean union period was ‎‎۸.۳±۲.۸ ‎months. Union complications (delayed or ‎nonunion) occurred in ۶ (۲۷.۳%) patients. ‎Fixation failed in ۵ (۲۲.۷%) patients (۳ nails and ۲ ‎plate fixation).‎Conclusions: AFF is associated with a prolonged union. ‎The intramedullary nail provides a more ‎secure fixation. Prodromal symptoms could be used for earlier detection of patients. ‎

نویسندگان

karim Pisoudeh

Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.

Kaveh Gharanizadeh

Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.

Mohammad Reza Naderan

Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.

Mohammadreza Sarshar

Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.

Masoud Mirkazemi

Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.

Hamed Tayebi

Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • ۱.Fleisch H, Reszka A, Rodan G, Rogers M ...
  • Bisphosphonates: mechanisms of action. Principles ofbone biology. ۲۰۰۲:۱۳۶۱-XLIII ...
  • ۲.Favus MJ. Bisphosphonates for osteoporosis. NewEngland Journal of Medicine. ۲۰۱۰;۳۶۳(۲۱):۲۰۲۷-۳۵ ...
  • ۳.Kennel KA, Drake MT. Adverse effects ofbisphosphonates: implications for osteoporosismanagement. ...
  • PubMed PMID: ۱۹۵۶۷۷۱۷. eng ...
  • ۴.Abrahamsen B. Bisphosphonate adverse effects,lessons from large databases. Current opinion ...
  • ۵.Papapetrou PD. Bisphosphonate-associated adverseevents. Hormones. ۲۰۰۹;۸(۲):۹۶-۱۱۰ ...
  • ۶.Giusti A, Hamdy NA, Papapoulos SE. Atypicalfractures of the femur ...
  • ۲۰۱۰;۴۷(۲):۱۶۹-۸۰ ...
  • ۷.Dell RM, Adams AL, Greene DF, Funahashi TT,Silverman SL, Eisemon ...
  • ۸.Shane E, Burr D, Ebeling PR, Abrahamsen B, AdlerRA, Brown ...
  • Journal of Bone and Mineral Research ...
  • ۲۰۱۰;۲۵(۱۱):۲۲۶۷-۹۴ ...
  • ۹.Saita Y, Ishijima M, Kaneko K. Atypical femoralfractures and bisphosphonate ...
  • ۱۰.Giaconi JC, Watterson CT. Bisphosphonate-RelatedAtypical Femur Fractures and Their RadiographicFeatures. ...
  • ۱۱.Pisoude K, Elahifar O, Sohrabi MB, Khajemozafari J ...
  • Comparison of proximal femur locking compressionplate and intramedullary nailing in ...
  • ۱۲.Eisenstein N, Kasavkar G, Bhavsar D, Khan FS,Paskins Z. Incidence ...
  • BMC musculoskeletal disorders. ۲۰۱۷;۱۸(۱):۱-۶ ...
  • ۱۳.Shin JS, Kim NC, Moon KH. Clinical features ofatypical femur ...
  • ۲۰۱۶;۲(۴):۲۴۴-۹ ...
  • ۱۴.Franceschetti P, Bondanelli M, Caruso G, AmbrosioMR, Lorusso V, Zatelli ...
  • ۱۵.Rajput IM, Kumar J, Siddiqui AA, Jamil M, SoughatM, Ahmed ...
  • ۲۰۱۹;۱۱(۵) ...
  • ۱۶.Sahemey R, Nikolaides A, Bhattacharya S, Simons A,Makrides P. Bisphosphonate-related ...
  • Journal of Orthopaedics, Trauma and Rehabilitation ...
  • ۲۰۲۰;۲۷(۲):۱۹۲-۷ ...
  • ۱۷.Bhadada SK, Sridhar S, Muthukrishnan J, Mithal A,Sharma DC, Bhansali ...
  • نمایش کامل مراجع